Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Low-dose doxycycline treats rosacea and gum disease through an anti-inflammatory pathway distinct from its antibiotic action—a genuine pharmacological discovery worth understanding.
Doxycycline prevents malaria by stopping the parasite before it can multiply—but only if taken on schedule. Here is the biology behind the regimen and the timing rules.
Doxycycline can cause an exaggerated sunburn through a specific chemical reaction in skin, not a drug allergy. Here is the mechanism and how to protect yourself.
A short, well-timed course of doxycycline clears early Lyme disease in most patients. Here's the evidence behind the ten-day standard and who should start treatment without delay.
Three tetracyclines, one shared origin, but real differences in absorption, tissue reach, and safety that matter when choosing a treatment.
A clear-eyed look at doxycycline's decades-long safety record, its real risks, and who should steer clear of it based on current clinical evidence.
Doxycycline's long half-life and near-complete absorption set it apart from older tetracyclines, shaping when and how it should be taken.
Doxycycline treats a specific range of bacterial infections, not bacteria in general. Here is what the clinical evidence actually shows about its uses, dosing, and timeline.
A clear, evidence-based guide to doxycycline covering dosing, food and alcohol interactions, timing, side effects, and how to know it's working.